News

Walter and Eliza Hall Institute news: Structure of protein pair provides blueprint for future drugs

Walter and Eliza Hall Institute researchers have visualised for the first time how the protein SOCS1 ‘switches off’ cell signalling to dampen immune responses and block cancer growth. The atomic-level structure of SOCS1 binding to its partner protein…

Job: Senior Development Scientist – Cancer Genetics / Epidemiology – Genetic Technologies Limited

Full-Time Position LOCATION: Fitzroy, Melbourne  Genetic Technologies Limited (ASX: GTG) is committed to translating recent advances in disease susceptibility genetics to clinically useful commercial assays for patient risk assessment and management activities. THE ROLE: The present opportunity would ideally…

Job: Research & Project Officer, Committee for Melbourne

About the Committee Committee for Melbourne is all about shaping a better future for Melbourne. Working together with our members, we make a difference by challenging the status quo and encouraging thought leadership to create change through confident and…

Job: Head of Drug Discovery, Adalta Limited

The Company AdAlta Limited (ASX:1AD) is a drug discovery and development company using its powerful technology platform to generate a promising new class of protein therapeutics, known as i-bodies, for treating a wide range of human diseases. The…

Job: Business Development Associate – Regional Trials Network

Grow the Cancer Clinical Trials Portfolio in Regional Victoria Part-time (0.8 FTE) Attractive remuneration package 12-month contract, with the possibility of extension Located in the Victorian Comprehensive Cancer Centre (VCCC) Building in Parkville, Cancer Trials Australia (CTA) is a…

Women Leading World-Class Health Innovation in Melbourne

Victoria grows globally competitive innovation-intensive companies. Innovation is a people-driven process that thrives on diverse thinking and views. Now that business is embracing the performance-based argument, successful women in and those aspiring towards leadership roles need recognition to…

Australia is backing health innovation industries to build future economy

Announced in the federal budget last night, the 21st century National Medical Industry Growth Plan will deliver $1.3 billion to support Australia as a global health innovation leader in medical technology, biotechnology and pharmaceuticals while improving health outcomes for…

Job: Project Manager | ASX Biotech

• New opportunity • Project Management • Drug Development | CMC Our Client Our client is an ASX listed clinical stage biotechnology company moving into an exciting and active time. Recent successful clinical trials have shown the technology…

New BioMelbourne Network Board Appointment – David Herd

The BioMelbourne Network Board was delighted to welcome David Herd as new Board Director at the most recent board meeting.  “BioMelbourne is a very active and positive contributor to shaping many aspects of our Industry and I am…

BioMelbourne Network gives State Budget 6/10 for the health innovation industry

BioMelbourne Network CEO Dr Krystal Evans welcomes the State Government of Victoria’s Budget yesterday, noting the significant investment in digital infrastructure, the Heart Hospital and the ongoing operational support for the Melbourne Biomedical Precinct. However, these initiatives are…

BioMelbourne Network Policy Principles – 2018 State Election

The biotechnology, medical technology and pharmaceutical sector in Victoria is vibrant and growing but yet to reach its full potential contribution to the Victorian economy. Historical support from governments has allowed the sector to grow, now employing 75,000…

Home

News & opinion

Member Directory

Events